Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M60.8Revenue (TTM) $M6.9Net Margin (%)-271.3Altman Z-Score-15.9
Enterprise Value $M43.3EPS (TTM) $-0.7Operating Margin %-273.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-272.4Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %--Quick Ratio3.8Cash flow > EarningsN
Price/Sales8.85-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-68.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-102.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PSDV is held by these investors:



PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Leonard SVice President, Finance 2016-01-04Sell5,000$4.7-62.13view
Ross Leonard SVice President, Finance 2015-12-22Sell33,950$5.39-66.98view
Ashton PaulPresident & CEO 2015-12-22Sell120,000$5.39-66.98view
Ross Leonard SVice President, Finance 2015-12-01Sell1,050$4.06-56.16view
Ross Leonard SVice President, Finance 2015-08-03Sell5,000$4.05-56.05view
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-58.31view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-62.76view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-59.27view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-58.8view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$4-55.5view

Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    Weekly CEO Sales Highlight: pSivida Corp., Equity Residential, Ciena Corp., Sabre Corp. Dec 28 2015 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 

    More From Other Websites
    PSIVIDA CORP. Financials Feb 15 2017
    pSivida to Present at the 2017 BIO CEO & Investor Conference Feb 10 2017
    PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report Feb 09 2017
    PSIVIDA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Feb 08 2017
    Edited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT Feb 07 2017
    PSivida posts 2Q loss Feb 07 2017
    PSivida posts 2Q loss Feb 07 2017
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 07 2017
    pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results Feb 07 2017
    Q2 2017 pSivida Corp Earnings Release - After Market Close Feb 07 2017
    pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and... Jan 25 2017
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 10 2017
    PSIVIDA CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in... Dec 30 2016
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Dec 23 2016
    PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 20 2016
    pSivida Corp. (PSDV): Here’s How It Stacks Up Versus Its Peers Dec 16 2016
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters... Dec 16 2016
    ETFs with exposure to pSivida Corp. : December 13, 2016 Dec 13 2016
    ETFs with exposure to pSivida Corp. : December 2, 2016 Dec 02 2016
    ETF’s with exposure to pSivida Corp. : November 10, 2016 Nov 10 2016
    pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2017 By the Numbers : November 9, 2016 Nov 09 2016
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Nov 08 2016
    Edited Transcript of PSDV earnings conference call or presentation 7-Nov-16 9:30pm GMT Nov 07 2016
    pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives... Nov 07 2016
    pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference... Oct 31 2016
    Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target Oct 04 2016
    pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist Sep 27 2016
    pSivida Reports Inducement Awards to New President and Chief Executive Officer Sep 20 2016
    pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO Sep 15 2016
    pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results Sep 12 2016
    pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and... Sep 01 2016
    pSivida Announces 13 New Patents Issued or Allowed Aug 29 2016
    Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter... Aug 09 2016
    pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer Aug 03 2016
    pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for... Aug 01 2016
    pSivida's Medidur™ Maintains Same High Statistical Significance in Primary Endpoint through 12... Jul 27 2016
    pSivida Corp. Announces Plan to Consolidate all Research and Development in Current U.S. Facility Jul 15 2016
    Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for... Jul 14 2016
    pSivida Announces Poster and Oral Presentation on Controlled Release of Avastin® from Tethadur™... Jul 08 2016
    pSivida Announces Successful Completion of Two Preclinical Studies of Durasert™ Sustained-Release... Jul 05 2016
    pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results May 05 2016
    pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics May 04 2016
    pSivida's Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe May 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)